Catalyst
Slingshot members are tracking this event:
Merck (MRK) and Pfizer (PFE) Plan to Submit NDA By End of 2016 for Ertugliflozin in Combination with Januvia (sitagliptin) and Metformin in Treatment of Type 2 Diabetes
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Mar 06, 2017
Occurred Source:
http://www.mercknewsroom.com/news-release/research-and-development-news/merck-and-pfizer-announce-us-fda-and-ema-filing-acceptanc
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
New Drug Applciation, Ertugliflozin, Januvia, Sitagliptin, Metformin, Type 2 Diabetes, Fda
